The Centers for Medicare & Medicaid Services yesterday issued an FAQ to outline COVID-19-related payment and grace period flexibilities for issuers offering coverage on the federally-facilitated exchanges and state-based exchanges on the federal platform. The agency says it will “exercise enforcement discretion” if issuers extend premium payment deadlines and delay cancellations or terminations of coverage for non-payment of premiums, assuming these are done with the permission of applicable state regulatory authorities. CMS also is encouraging state-based exchanges to take a similar approach. CMS also released the following FAQs:

Related News Articles

Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study  released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…